Other OTC - Delayed Quote • USD
Acura Pharmaceuticals, Inc. (ACUR)
At close: April 19 at 10:26 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2017) | Next Qtr. (Sep 2017) | Current Year (2017) | Next Year (2018) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.28 | -0.19 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2017) | Next Qtr. (Sep 2017) | Current Year (2017) | Next Year (2018) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 92k | 83k | 2.97M | 31.7M |
| Low Estimate | 340k | 360k | 1.4M | 31.7M |
| High Estimate | 340k | 360k | 1.4M | 31.7M |
| Year Ago Sales | 257k | 218k | 4.46M | 2.97M |
| Sales Growth (year/est) | -64.20% | -61.90% | -33.60% | 968.80% |
Earnings History
| CURRENCY IN USD | 6/30/2016 | 9/30/2016 | 12/31/2016 | 3/31/2017 |
|---|---|---|---|---|
| EPS Est. | -0.28 | -0.27 | -0.27 | -0.11 |
| EPS Actual | -0.28 | -0.19 | 0.13 | 0.03 |
| Difference | 0 | 0.08 | 0.4 | 0.14 |
| Surprise % | 0.00% | 29.60% | 148.10% | 127.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2017) | Next Qtr. (Sep 2017) | Current Year (2017) | Next Year (2018) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.11 | -0.12 | -0.46 | 0.37 |
| 30 Days Ago | -0.11 | -0.12 | -0.46 | 0.37 |
| 60 Days Ago | -0.11 | -0.12 | -0.46 | 0.37 |
| 90 Days Ago | -0.11 | -0.12 | -0.46 | 0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2017) | Next Qtr. (Sep 2017) | Current Year (2017) | Next Year (2018) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ACUR | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.40% |
| Next Qtr. | -- | -- | -- | 9.90% |
| Current Year | -- | -- | -- | 4.30% |
| Next Year | -- | -- | -- | 13.40% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | 58.88% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Roth Capital: Buy | 3/11/2016 |
| Upgrade | MLV & Co.: Hold to Buy | 2/27/2015 |
| Downgrade | MLV & Co.: Buy to Hold | 5/28/2014 |
| Initiated | McNicoll Lewis Vlak: Buy | 8/14/2013 |
Related Tickers
CLVRW Clever Leaves Holdings Inc.
0.0400
0.00%
BFRIW Biofrontera Inc.
0.0499
0.00%
ALIM Alimera Sciences, Inc.
3.5900
+1.41%
TKNO Alpha Teknova, Inc.
1.7990
-10.05%
GHSI Guardion Health Sciences, Inc.
8.28
+3.24%
SHPH Shuttle Pharmaceuticals Holdings, Inc.
0.3880
+0.26%
IXHL Incannex Healthcare Inc.
2.2800
-2.98%
AZFL Amazonas Florestal, Ltd
0.0000
0.00%
EVOK Evoke Pharma, Inc.
0.4435
-2.10%
AYTU Aytu BioPharma, Inc.
2.7150
-2.34%